United States Food and Drug Administration (USFDA) has concluded audit at Jubilant Pharmova’s wholly-owned subsidiary -- Jubilant HollisterStier’s subsidiary -- Jubilant HollisterStier General Partnership’s (JHSGP) contract manufacturing facility located in Montreal, Canada. The USFDA has issued 15 observations pursuant to the completion of audit. JHSGP will submit an action plan on the observations.
Jubilant Pharmova (formerly Jubilant Life Sciences) is a company engaged in pharmaceuticals, contract research and development services and proprietary novel drugs businesses.
